Medpace Holdings MEDP
NASDAQ MEDP
$615.11 -1.33 (-0.22%)
As of: Sep 17, 2026 · 3:59 PM EDT

Medpace Holdings (MEDP) Non-Current Assets (2015 - 2026)

Medpace Holdings' (MEDP) quarterly Non-Current Assets came in at $1.0 billion in Q2 2026, down 4.18% on a YoY basis from $1.1 billion in Q2 2025, and up 1.65% quarter-over-quarter from $990.6 million in Q1 2026.

Analysis

Medpace Holdings (MEDP) Non-Current Assets (2015 - 2026) Analysis & Trends

Medpace Holdings (MEDP) has reported Non-Current Assets for 12 consecutive years, with $1.0 billion the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Non-Current Assets fell 4.18% year-over-year to $1.0 billion; the trailing twelve-month figure through Jun 2026 stood at $4.0 billion (down 5.9% YoY), and the FY2025 full-year result was $985.8 million, down 8.01% from the prior year.
  • Non-Current Assets rose to $1.0 billion in Q2 2026 per MEDP's latest filing, from $990.6 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $1.1 billion in Q1 2025 and bottomed at $985.8 million in Q4 2025.
  • Historically, Non-Current Assets has averaged $1.0 billion across 5 years, with a median of $1.0 billion in 2023.
  • The sharpest annual moves came in 2022 and 2025: Non-Current Assets increased 7.67% in 2022, then decreased 8.01% in 2025.
  • Over 5 years, Non-Current Assets stood at $1.0 billion in 2022, then advanced by 4.37% to $1.1 billion in 2023, then increased by 0.81% to $1.1 billion in 2024, then slipped by 8.01% to $985.8 million in 2025, then grew by 2.14% to $1.0 billion in 2026.
  • According to Business Quant data, Non-Current Assets over the past three periods registered $1.0 billion, $990.6 million, and $985.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 23.66 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 1.01 Bn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 12.65 Bn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 6.00 Bn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 1.79 Bn
6 Evotec SE 574.75 Mn 148.87 Mn - 982.30 Mn
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 657.51 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 14.00 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn 3.66 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - 621,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.01 Bn
Mar 31, 2026 990.56 Mn
Dec 31, 2025 985.85 Mn
Sep 30, 2025 1.02 Bn
Jun 30, 2025 1.05 Bn
Mar 31, 2025 1.08 Bn
Dec 31, 2024 1.07 Bn
Sep 30, 2024 1.05 Bn
Jun 30, 2024 1.05 Bn
Mar 31, 2024 1.05 Bn
Dec 31, 2023 1.06 Bn
Sep 30, 2023 1.04 Bn
Jun 30, 2023 1.03 Bn
Mar 31, 2023 1.03 Bn
Dec 31, 2022 1.02 Bn
Sep 30, 2022 990.68 Mn
Jun 30, 2022 986.57 Mn
Mar 31, 2022 988.38 Mn
Dec 31, 2021 969.02 Mn
Sep 30, 2021 935.92 Mn